Keywords: Roche, Breast cancer, Avastin, Herceptin, Research

US FDA clears restart of Roche Ph III Avastin trials; other strong data presented at San Antonio meeting

Article | 14 December 2009

Print This

The US Food and Drug Administration is permitting Swiss drug major Roche to resume enrolment in a Phase III trial ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in